What is the debt of Rezolute this year?
Rezolute has a debt level of -16 USD this year.
Rezolute Debt 2024
Rezolute Debt
-16 USD
Ticker
RZLT
ISIN
US76200L3096
In 2024, Rezolute's total debt was -16 USD, a -89.36% change from the -150.4 USD total debt recorded in the previous year.
Rezolute Aktienanalyse
What does Rezolute do?
Rezolute Inc. is a bio-pharmaceutical company that was founded in 2010 in California. The company specializes in the research and development of innovative therapies for the treatment of rare metabolic and endocrine diseases. The business model of Rezolute is to develop innovative solutions and treatment approaches for diseases that currently have insufficient treatment options. The company is actively working to expand its product pipeline and explore new treatment methods in order to give hope and prospects for a better quality of life to suffering patients. Rezolute is active in three main areas: diabetes and metabolic diseases, diseases of the endocrine system, and protein-based therapy platforms. Each of these areas is of great importance in combating rare diseases that are often overlooked by the pharmaceutical industry. The diabetes and metabolic diseases category is the core business of Rezolute Inc. The company strives to develop innovative therapies for the treatment of diabetes itself and its comorbidities. This includes diseases of the cardiovascular system and kidney diseases, which are common among diabetes patients. In the category of endocrine diseases, the company is working on the development of targeted therapies for the treatment of diseases such as hypothyroidism (an underactive thyroid) and hypopituitarism (a deficiency of hormones produced by the pituitary gland). These diseases are often overlooked by the pharmaceutical industry as they occur less frequently compared to other diseases. The protein-based therapy platforms are technologically advanced and have the potential to offer new treatment options. Rezolute utilizes its own proprietary technologies for the development of immunoglobulins and drugs that specifically target certain molecules. The company is also researching compounds that can influence the immune system to combat inflammation and autoimmune diseases. Rezolute currently has several therapy options in development. The company is working on RZ358, an oral insulin formulation for the treatment of diabetes; RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas); and RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas). The company has also obtained orphan drug status to develop RZ358, its innovative therapy for the treatment of Congenital Hyperinsulinism (CHI), a rare, congenital endocrine disorder. Rezolute has established itself as an important player in the global bio-pharmaceutical market. The company is committed to improving the lives of patients suffering from rare diseases by developing innovative treatment options. With a dedicated team of scientists and researchers, the company strives to push the boundaries of science and develop the next generation of innovative therapies that have the potential to improve the lives of patients. Rezolute ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Rezolute's Debt Structure
Rezolute's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Rezolute's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Rezolute’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Rezolute’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Rezolute stock
What was the debt of Rezolute compared to the previous year?
The debt of Rezolute has increased by -89.36% compared to the previous year dropped.
What are the consequences of high debt for investors in Rezolute?
High debt can pose a risk for investors of Rezolute, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Rezolute?
Low debt means that Rezolute has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Rezolute affect the company?
An increase in debt of Rezolute can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Rezolute affect the company?
A reduction in debt of Rezolute can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Rezolute?
Some factors that can influence the debt of Rezolute include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Rezolute so important for investors?
The debts of Rezolute are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Rezolute take to change the debt?
To change the debt, Rezolute can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Rezolute pay?
Over the past 12 months, Rezolute paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rezolute is expected to pay a dividend of 0 USD.
What is the dividend yield of Rezolute?
The current dividend yield of Rezolute is .
When does Rezolute pay dividends?
Rezolute pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Rezolute?
Rezolute paid dividends every year for the past 0 years.
What is the dividend of Rezolute?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Rezolute located?
Rezolute is assigned to the 'Health' sector.
Wann musste ich die Aktien von Rezolute kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Rezolute from 10/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2024.
When did Rezolute pay the last dividend?
The last dividend was paid out on 10/8/2024.
What was the dividend of Rezolute in the year 2023?
In the year 2023, Rezolute distributed 0 USD as dividends.
In which currency does Rezolute pay out the dividend?
The dividends of Rezolute are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Rezolute
Our stock analysis for Rezolute Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rezolute Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
